BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28458156)

  • 1. Protective effect of Hua Tan Qu Shi decoction against liver injury in rats with nonalcoholic fatty liver disease.
    Zhao SP; Wu ZS; Chen Y; Liang X; Bao L; Li P; Sun RR; Wu YL; Li LR; Wang Q
    Biomed Pharmacother; 2017 Jul; 91():181-190. PubMed ID: 28458156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.
    Zaitone SA; Barakat BM; Bilasy SE; Fawzy MS; Abdelaziz EZ; Farag NE
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):587-600. PubMed ID: 25708949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipidomic Analysis of the Protective Effects of Shenling Baizhu San on Non-Alcoholic Fatty Liver Disease in Rats.
    Deng Y; Pan M; Nie H; Zheng C; Tang K; Zhang Y; Yang Q
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31683679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
    Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
    Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural products berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin.
    Feng WW; Kuang SY; Tu C; Ma ZJ; Pang JY; Wang YH; Zang QC; Liu TS; Zhao YL; Xiao XH; Wang JB
    Biomed Pharmacother; 2018 Mar; 99():325-333. PubMed ID: 29353208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects and mechanisms of total alkaloids of Rubus alceaefolius Poir on non‑alcoholic fatty liver disease in rats.
    Zheng H; Zhao J; Zheng Y; Wu J; Liu Y; Peng J; Hong Z
    Mol Med Rep; 2014 Oct; 10(4):1758-64. PubMed ID: 25051256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of modified sini decoction on liver injury and regeneration in acute liver failure induced by D-galactosamine in rats.
    Luo J; Zhang Y; Hu X; Zhong S; Chen G; Wang Y; Lin W; Yi C; Zhu H
    J Ethnopharmacol; 2015 Feb; 161():53-9. PubMed ID: 25499312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats.
    Elshazly SM
    Eur J Pharmacol; 2015 Feb; 748():123-32. PubMed ID: 25542756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice.
    Zhang L; Yang B; Yu B
    Biol Pharm Bull; 2015; 38(7):1005-11. PubMed ID: 25972092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grape Leucoanthocyanidin Protects Liver Tissue in Albino Rabbits with Nonalcoholic Hepatic Steatosis.
    Franklin R; Bispo RFM; Sousa-Rodrigues CF; Pires LAS; Fonseca A; Babinski MA
    Cells Tissues Organs; 2018; 205(3):129-136. PubMed ID: 29913455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatic aldehyde compound cuminaldehyde protects nonalcoholic fatty liver disease in rats feeding high fat diet.
    Haque MR; Ansari SH
    Hum Exp Toxicol; 2019 Jul; 38(7):823-832. PubMed ID: 30974975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carnosic acid protects non-alcoholic fatty liver-induced dopaminergic neuron injury in rats.
    Xu T; Zhou J; Zhu J; Zhang S; Zhang N; Zhao Y; Ding C; Shi X; Yao J
    Metab Brain Dis; 2017 Apr; 32(2):483-491. PubMed ID: 27957651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jiangzhi Ligan Decoction Inhibits GSDMD-Mediated Canonical/Noncanonical Pyroptosis Pathways and Alleviates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease.
    Yin K; Zhou X; Jiang W; Wang L; Dai Z; Tang B
    Dis Markers; 2021; 2021():9963534. PubMed ID: 34239622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Euterpe edulis Extract but Not Oil Enhances Antioxidant Defenses and Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Rats.
    Freitas RB; Novaes RD; Gonçalves RV; Mendonça BG; Santos EC; Ribeiro AQ; Lima LM; Fietto LG; Peluzio Mdo C; Leite JP
    Oxid Med Cell Longev; 2016; 2016():8173876. PubMed ID: 27418954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Effect of Fuzi Lizhong Decoction against Non-alcoholic Fatty Liver Disease via Anti-inflammatory Response through Regulating p53 and PPARG Signaling.
    Yang J; Ma W; Mei Q; Song J; Shu L; Zhang S; Li C; An L; Du N; Shi Z
    Biol Pharm Bull; 2020; 43(11):1626-1633. PubMed ID: 33132309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
    Hong XZ; Li LD; Wu LM
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice.
    Li S; Qian Y; Xie R; Li Y; Jia Z; Zhang Z; Huang R; Tuo L; Quan Y; Yu Z; Liu J; Xiang M
    J Ethnopharmacol; 2019 Oct; 242():112029. PubMed ID: 31216433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
    Liu J; Han L; Zhu L; Yu Y
    Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silibinin Capsules improves high fat diet-induced nonalcoholic fatty liver disease in hamsters through modifying hepatic de novo lipogenesis and fatty acid oxidation.
    Cui CX; Deng JN; Yan L; Liu YY; Fan JY; Mu HN; Sun HY; Wang YH; Han JY
    J Ethnopharmacol; 2017 Aug; 208():24-35. PubMed ID: 28648927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemisia capillaris formula inhibits hepatic steatosis via an miR‑122‑induced decrease in fatty acid synthase expression in vivo and in vitro.
    Liu L; Zhao J; Li Y; Wan Y; Lin J; Shen A; Xu W; Li H; Zhang Y; Xu J; Peng J; Hong Z
    Mol Med Rep; 2016 Jun; 13(6):4751-8. PubMed ID: 27081834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.